News: Chronic Myelomonocytic Leukaemia
$1.62 million for rare cancer research
![Image of blood vials in a laboratory](/newsroom/sites/default/files/styles/ua_landscape/public/media/images/2020-06/blood-4944421_1920-pixabay.jpg?h=e5aec6c8&itok=jdMlSaE6)
A University of Adelaide and SAHMRI study to test new treatments for a rare and neglected blood cancer, which has no known effective treatment, has been awarded $1,619,122 from the Federal Government’s Medical Research Future Fund (MRFF).